1. P368 Ross procedure: homograft deterioration, clinical outcomes and predictors after 21 years follow up. A single center experience
- Author
-
L Carnero Montoro, M Ruiz Ortiz, A Luque Moreno, R Villalba Montoro, M J Oneto Fernandez, D Mesa Rubio, R Gonzalez Manzanares, A Fernandez Ruiz, N Paredes Hurtado, L Pardo Gonzalez, C Merino Cejas, M Delgado Ortega, M Pan Alvarez-Ossorio, C Pericet Rodriguez, and A Rodriguez Amodovar
- Subjects
medicine.medical_specialty ,business.industry ,Ross procedure ,medicine.medical_treatment ,General surgery ,medicine ,Radiology, Nuclear Medicine and imaging ,General Medicine ,Cardiology and Cardiovascular Medicine ,Single Center ,business - Abstract
Background and purpose Pulmonary homograft stenosis can appear in long-term follow-up after Ross intervention. Our aim was to describe the incidence, clinical impact and predictors of homograft stenosis and reintervention after the Ross procedure in a prospective series in a tertiary referral hospital after 21 years followup. Methods From 1997 to 2009, 107 patients underwent the Ross procedure (mean age: 30 ± 11 years; 69% men; 21 aged 36 mmHg) and surgical or percutaneous homograft reintervention. Results At the end of follow-up (21 years, median: 17 years, interquartile rank 12-19 years), echocardiographic and clinical data were available in 95 (89%) and 105 (98%) patients, respectively: 28/95 (29%) patients developed homograft stenosis and 13/105 (12%) patients underwent diferent homograft reintervention procedures (five patients underwent surgical replacement, four received a percutaneous pulmonary valve and one needed stent implantation). The other three patients underwent two or even three consecutive procedures in follow-up; two died because of complications after percutaneous pulmonary valve implantation and other one after surgical replacement. Rates of survival free from homograft stenosis and reintervention at the end of the follow-up were 71% and 88%, respectively. Younger age, and especially being part of paediatric group ( time predicted worse survival free from homograft stenosis (hazard ratio [HR] 3.88, 95% confidence interval [CI]: 1.78-8,43; p = 0.001), although there were no significant differences regarding reintervention (HR 1.54, [CI] 95% 0.42-5.58, p = 0.52). We found no significant association of this outcome with previous cardiac surgery, donor age, donor or recipient sex, homograft size, time of freezing or congenital aetiology. Conclusions After 21 years follow-up, incidence of homograft stenosis and reintervention after the Ross procedure were 29% and 12%, respectively; three patients had a reintervention-related death. Younger recipient age at Ross procedure was associated with a higher rate of stenosis.
- Published
- 2020
- Full Text
- View/download PDF